CLRB - Company ID 0001279704
Cellectar Biosciences, Inc. (CLRB) reported net income of -$21.79M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$21.79M | +51.1% |
| FY 2024 | -$44.58M | -17.4% |
| FY 2023 | -$37.98M | -19.5% |
| FY 2022 | -$31.79M | -31.8% |
| FY 2021 | -$24.12M | -59.8% |
| FY 2020 | -$15.09M | -7.1% |
| FY 2019 | -$14.09M | -6.4% |
| FY 2018 | -$13.24M | +2.4% |
| FY 2017 |
Cellectar Biosciences, Inc. (CLRB) reported net income of -$21.79M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, Cellectar Biosciences, Inc.'s net income declined from -$7.44M to -$21.79M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$13.56M |
| -119.4% |
| FY 2016 | -$6.18M | -12.5% |
| FY 2015 | -$5.50M | +31.8% |
| FY 2014 | -$8.05M | +25.3% |
| FY 2013 | -$10.78M | -22.6% |
| FY 2012 | -$8.80M | -18.3% |
| FY 2011 | -$7.44M | - |